CLINICAL TRIALS PROFILE FOR GADOPENTETATE DIMEGLUMINE
✉ Email this page to a colleague
All Clinical Trials for GADOPENTETATE DIMEGLUMINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004936 ↗ | MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients | Completed | National Cancer Institute (NCI) | N/A | 2000-04-01 | RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients. |
| NCT00004936 ↗ | MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients | Completed | American College of Radiology Imaging Network | N/A | 2000-04-01 | RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients. |
| NCT00033397 ↗ | Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery | Completed | National Cancer Institute (NCI) | 2002-02-01 | RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer. | |
| NCT00033397 ↗ | Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery | Completed | Alliance for Clinical Trials in Oncology | 2002-02-01 | RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer. | |
| NCT00310544 ↗ | Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction | Completed | Bayer | Phase 2 | 2006-03-01 | The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle. |
| NCT00310596 ↗ | Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects | Completed | Bayer | Phase 1 | 2004-01-01 | The purpose of this study is to determine what effect Magnevist (gadopentetate dimeglumine) injection has on the way the heart conducts the electrical impulses that allow it to beat effectively. The study will compare Magnevist injection's effect to that of placebo (a saline injection). |
| NCT00375830 ↗ | Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases | Completed | Stanford University | Phase 2 | 2006-01-01 | This clinical trial studies the use of sodium fluorine-18 (18F-NaF) plus fluorine-18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET)/ whole body magnetic resonance imaging (WBMRI) to detect skeletal metastases in patients with stage III-IV breast cancer or stage II-IV prostate cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GADOPENTETATE DIMEGLUMINE
Condition Name
Clinical Trial Locations for GADOPENTETATE DIMEGLUMINE
Trials by Country
Clinical Trial Progress for GADOPENTETATE DIMEGLUMINE
Clinical Trial Phase
Clinical Trial Sponsors for GADOPENTETATE DIMEGLUMINE
Sponsor Name
